Western Blotting Top Companies - Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Western Blotting Market Size Analysis and Top Companies

The global western blotting market size is expected to reach around USD 1,860.86 million by 2033 from USD 989.47 million in 2023, expanding at a CAGR of 6.52% from 2024 to 2033 The top companies operating in the western blotting are Leinco Technologies, Takara Bio Inc., ICL, Inc., Cell Signaling Technology, Inc., GenScript, ElabScience Biotechnology Inc., HiMedia Laboratories, Azure Biosystem Inc., Advansta Inc, SBH Sciences, Bio-Techne, LI-COR, Inc., Bio-Rad Laboratories, Merck KGaA, Lumigen, Inc., Hoffmann-La Roche Ltd, GE Healthcare, Thermo Fischer Scientific Inc.,and Others.

Market Report Coverage

Anesthesia Drugs Key Players

• Leinco Technologies
• Takara Bio Inc.
• ICL, Inc.
• Cell Signaling Technology, Inc.
• GenScript
• ElabScience Biotechnology Inc.
• HiMedia Laboratories
• Azure Biosystem Inc.
• Advansta Inc
• SBH Sciences
• Bio-Techne
• LI-COR, Inc.
• Bio-Rad Laboratories
• Merck KGaA
• Lumigen, Inc.
• Hoffmann-La Roche Ltd
• GE Healthcare
• Thermo Fischer Scientific Inc.

Recent Developments

• In January 2022, Bio-Techne launched their stellar NIR spectroscopy/IR (near-infrared spectroscopy/infrared) detection modules for an automated multichannel traditional western blotting system, Jess, under the ProteinSimple brand.
• In February 2024, a new product line offering anti-HCP antibodies with greater than 95% coverage was launched by a leading proteomics service provider, Applied Biomics, Inc. The company provides Anti-E. Coli, Anti-CHO, and Anti-HEK293 HCP antibodies. These antibodies can be used for immune-precipitation, ELISA, 1D, or 2D western blotting.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344